# Amundi CAC 40 Daily (-2X) Inverse UCITS ETF -Acc- (0MRI) **Page:** https://fundology.uk/fund/0mri · ISIN FR0010411884 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, 0MRI (Amundi CAC 40 Daily (-2X) Inverse UCITS ETF -Acc-, ISIN FR0010411884) closed at €0.6007 on the London Stock Exchange. Its ongoing charge is 0.60% a year (about £60 on £10,000). Over the five years to 13/11/2026 its total return was −53.8%, or −63.9% after UK CPIH inflation. ## Summary Amundi CAC 40 Daily (-2X) Inverse UCITS ETF -Acc- is an exchange-traded fund (ETF) from Amundi, launched in 2007. It aims to deliver a multiple, or the opposite, of one day’s move in what it tracks. The multiple resets daily, so over longer periods its return can differ a lot from the multiple of the index return. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.6% a year — about £60 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. > **Leveraged & inverse:** Built for short-term trading. Because the multiple resets every day, losses can build up quickly when held for longer, even if the index ends up where it started. Latest close: **€0.6007** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | 0MRI | | ISIN | FR0010411884 | | Category | Leveraged & inverse | | Type | ETF | | Provider | Amundi | | Tracks | France CAC 40 Double Short | | Income | Accumulating | | Ongoing charge | 0.60% a year (£60 per £10,000) | | Fund size | £127m | | Launched | 2007 | | Domicile | France | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | -12.74% | -15.83% | income reinvested | | 3 years | -37.17% | -43.23% | income reinvested | | 5 years | -53.76% | -63.90% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Calendar-year returns Calendar-year returns of Amundi CAC 40 Daily (-2X) Inverse UCITS ETF -Acc- in pounds (price, with income reinvested in the fund): 2022 +1.0%, 2023 −29.3%, 2024 +1.9%, 2025 −21.3%; 2026 to 13/11/2026 −13.5%. Returns of Amundi CAC 40 Daily (-2X) Inverse UCITS ETF -Acc- in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: −5.2%; to 30/09/2025: −9.1%; to 30/09/2024: −18.4%; to 30/09/2023: −41.1%; to 30/09/2022: +5.7%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | +1.0% | -7.6% | Price | | 2023 | -29.3% | -32.1% | Price | | 2024 | +1.9% | -1.6% | Price | | 2025 | -21.3% | -24.0% | Price | | 2026 to 13/11/2026 | -13.5% | -16.3% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 29.11% | -26.83% | | 3 years | 29.95% | -43.66% | | 5 years | 32.48% | -65.01% | ## Largest fall Volatility of Amundi CAC 40 Daily (-2X) Inverse UCITS ETF -Acc- in pounds, annualised from weekly returns to 13/11/2026: 29.1% over 1 year, 29.9% over 3 years, 32.5% over 5 years. Largest fall in the price of Amundi CAC 40 Daily (-2X) Inverse UCITS ETF -Acc- since November 2021, in pounds: −65.0% from 30/09/2022 to 12/08/2026. The lowest 12-month return of Amundi CAC 40 Daily (-2X) Inverse UCITS ETF -Acc- in pounds (price, with income reinvested in the fund) since January 2021 was −50.4% (12 months to 28/01/2022); the highest was +24.9% (12 months to 11/04/2025). On 13/11/2026 the price of Amundi CAC 40 Daily (-2X) Inverse UCITS ETF -Acc- was 62.8% below its highest weekly close since November 2021 (30/09/2022), in pounds. ## Charges compared with similar funds Ongoing charge of Amundi CAC 40 Daily (-2X) Inverse UCITS ETF -Acc- 0.60% a year. Compared on 14/11/2026, 171 of the 210 other leveraged and inverse products charge more, 13 the same and 26 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.60%** per year (as of 13/11/2026) - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## What it holds 0MRI is a swap-based (synthetic) fund: it gets the return of the index it tracks through a swap. Its published holdings, as of 11/11/2026, are the substitute basket of securities the fund holds as collateral, not the companies in that index. ### Top holdings Largest positions (as of 11/11/2026), as a percentage of the whole fund: | # | Holding | Ticker | Weight | |---|---|---|---| | 1 | ASML | [ASML](https://fundology.uk/stock/ASML) | 9.40% | | 2 | Novo Nordisk | [NOVO_B](https://fundology.uk/stock/NOVO_B) | 9.15% | | 3 | Iss | [ISS](https://fundology.uk/stock/ISS) | 9.11% | | 4 | Airbus | [AIR](https://fundology.uk/stock/AIR) | 7.90% | | 5 | Infineon Technologies | [IFX](https://fundology.uk/stock/IFX) | 4.63% | | 6 | Siemens | [SIE](https://fundology.uk/stock/SIE) | 4.54% | | 7 | ING Groep | [INGA](https://fundology.uk/stock/INGA) | 4.50% | | 8 | NN Group | [NN](https://fundology.uk/stock/NN) | 4.47% | | 9 | Danske Bank | [DANSKE](https://fundology.uk/stock/DANSKE) | 4.46% | | 10 | Telenor | [TEL](https://fundology.uk/stock/OSL:TEL) | 4.45% | The 44 holdings on record (of 53 reported): https://fundology.uk/fund/0mri/holdings ## Questions people ask **What is the ongoing charge of 0MRI?** The ongoing charge of 0MRI is 0.60% a year — about £60 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Amundi CAC 40 Daily (-2X) Inverse UCITS ETF -Acc- 0.60% a year. Compared on 14/11/2026, 171 of the 210 other leveraged and inverse products charge more, 13 the same and 26 less (share classes counted once). **What does 0MRI track?** 0MRI tracks the France CAC 40 Double Short. **Is 0MRI accumulating or distributing?** 0MRI is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of 0MRI?** The ISIN of 0MRI is FR0010411884. An ISIN identifies one exact share class of a fund; 0MRI is its ticker on the London Stock Exchange. **What does 0MRI hold?** 0MRI is a swap-based (synthetic) fund: it gets the return of the index it tracks through a swap. Its published holdings, as of 11/11/2026, are the substitute basket of securities the fund holds as collateral, not the companies in that index. **What were 0MRI’s returns in each of the last five years?** Calendar-year returns of 0MRI in pounds (price, with income reinvested in the fund): 2022 +1.0%, 2023 −29.3%, 2024 +1.9%, 2025 −21.3%; 2026 to 13/11/2026 −13.5%. Past performance is not a guide to future returns. **How has 0MRI done after inflation?** Over the five years to 13/11/2026 0MRI’s total return was −53.8%, or −63.9% after UK CPIH inflation. Past performance is not a guide to future returns. ## Fund documents - [Fund page at Amundi](https://www.amundietf.co.uk/en/professional/products/equity/amundi-cac-40-daily-2x-inverse-ucits-etf-acc/fr0010411884) - Links checked 12/10/2026. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.